Avoiding Undertreatment, Overtreatment in Geriatric Breast Cancer Patients

Video

This video reviews how to ensure that older breast cancer patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.

A paradox exists in the treatment of older breast cancer patients. This population has a higher risk of dying from their breast cancer and in many cases patients are being undertreated, as some can safely receive more effective treatments based on their specific disease characteristics.

But older patients also have a higher risk of dying from other causes compared with younger populations, and the risk of overtreatment is a serious consideration.

In this video, Hans Wildiers, MD, PhD, of University Hospitals Leuven in Belgium, discusses how to ensure that these patients are receiving the most appropriate care and highlights population studies that can help inform individual treatment decisions.

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content